ORIENTBIO
오리엔트바이오KRX: 002630· Fiscal year 2025· orientbio.co.kr ↗
Average salary
$24.7K
₩32.9M
▲ 7.9% vs 2024
Employees
123
▲ 16.0% vs 2024
Average tenure
4.4 yrs
Estimated take-home of this pay:$1.8K / monthCalculate →
Workplace
Women's pay (men = 100)72
Women among staff50.4%
Contract staff0%
Recent official filings
- 2026-11-16Half-year report (2026.09)
- 2026-08-14Quarterly report (2026.06)
- 2026-06-23MajorCapital reduction
- 2026-06-19Annual report (2026.03)
Quick read
- Average pay is 46% below the median of the companies we track.
- Average pay rose 7.9% from 2024.
- Headcount grew by 17 (16.0%) from 2024.
- Ranks #236 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue grew 5.0% year over year.
- Operating loss of $2.3M in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $179.0K
- Net profit per employee
- -$80.3K
- Operating margin
- -10.5%
- Net margin
- -44.9%
- ROE
- -18.4%
- Debt-to-equity
- 18.0%
- Equity ratio
- 84.7%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.